MA30271B1 - Dibenzylamines et derives - Google Patents
Dibenzylamines et derivesInfo
- Publication number
- MA30271B1 MA30271B1 MA31225A MA31225A MA30271B1 MA 30271 B1 MA30271 B1 MA 30271B1 MA 31225 A MA31225 A MA 31225A MA 31225 A MA31225 A MA 31225A MA 30271 B1 MA30271 B1 MA 30271B1
- Authority
- MA
- Morocco
- Prior art keywords
- cholesterol
- dibenzylamines
- derivatives
- ldl
- triglycerides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Dibenzylamines et dérivés Des dibenzylamines et dérivés de dibenzylamines, des compositions pharmaceutiques contenant ces composés et l'utilisation de ces composés pour élever les taux plasmatiques de certains lipides, comprenant le cholestérol-liprotéines haute densité et pour abaisser les taux plasmatiques de certains autres lipides, tels que le cholestérol-LDL et les triglycérides et, en conséquence, pour traiter des maladies qui sont exacerbées par des taux bas de cholestérol-HDL et/ou des taux élevés de cholestérol-LDL et de triglycérides, telles que l'athérosclérose et des maladies cardiovasculaires chez certains mammifères, y compris les êtres humains.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78099306P | 2006-03-10 | 2006-03-10 | |
US11/619,277 US7919506B2 (en) | 2006-03-10 | 2007-01-03 | Dibenzyl amine compounds and derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30271B1 true MA30271B1 (fr) | 2009-03-02 |
Family
ID=38088523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31225A MA30271B1 (fr) | 2006-03-10 | 2008-09-10 | Dibenzylamines et derives |
Country Status (26)
Country | Link |
---|---|
US (1) | US7919506B2 (fr) |
EP (1) | EP1996564A1 (fr) |
JP (1) | JP5075843B2 (fr) |
KR (1) | KR101058312B1 (fr) |
AP (1) | AP2008004604A0 (fr) |
AR (1) | AR059803A1 (fr) |
AU (1) | AU2007226261B2 (fr) |
BR (1) | BRPI0709003A2 (fr) |
CA (2) | CA2645294C (fr) |
CR (1) | CR10264A (fr) |
DO (1) | DOP2007000047A (fr) |
EA (1) | EA200801815A1 (fr) |
EC (1) | ECSP088729A (fr) |
GT (1) | GT200700020A (fr) |
IL (1) | IL193571A (fr) |
MA (1) | MA30271B1 (fr) |
MX (1) | MX2008010863A (fr) |
NL (1) | NL2000514C2 (fr) |
NO (1) | NO20083641L (fr) |
PE (1) | PE20080118A1 (fr) |
RS (1) | RS20080410A (fr) |
SG (1) | SG176418A1 (fr) |
TN (1) | TNSN08347A1 (fr) |
TW (1) | TW200738652A (fr) |
UY (1) | UY30196A1 (fr) |
WO (1) | WO2007105050A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8383660B2 (en) * | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
EP2612669A4 (fr) | 2010-08-31 | 2014-05-14 | Snu R&Db Foundation | Utilisation de la reprogrammation f tale d'un agoniste des ppar |
CN103351354B (zh) * | 2013-06-09 | 2015-08-12 | 西安近代化学研究所 | 1-甲基-5-氨基四唑合成方法 |
CN103524445A (zh) * | 2013-09-09 | 2014-01-22 | 南通市华峰化工有限责任公司 | 一种1-甲基-5氨基四氮唑的合成生产方法 |
CN105793243A (zh) * | 2013-12-05 | 2016-07-20 | 拜耳作物科学股份公司 | N-环烷基-n-{[2-(1-取代的环烷基)苯基]亚甲基}-(硫代)甲酰胺衍生物 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562A (en) | 1844-04-25 | Improvement in seed-planters | ||
US30577A (en) | 1860-11-06 | Truss-bridge | ||
US2161938A (en) | 1934-07-31 | 1939-06-13 | Soc Of Chemical Ind | Imidazolines |
DE905738C (de) | 1943-06-11 | 1954-11-02 | Diwag Chemische Fabriken Ag | Verfahren zur Herstellung basischer Thymoldimethylaminoaethylaether |
FR1165845A (fr) | 1955-05-28 | 1958-10-29 | Philips Nv | Amines secondaires portant des substituants et leur préparation |
CH366523A (de) | 1958-04-14 | 1963-01-15 | Eprova Ag | Verfahren zur Herstellung der neuen 1,3,4,6- und 1,3,4,5-Tetranicotinoyl-fructose |
BE578515A (fr) | 1958-05-07 | |||
US2970082A (en) | 1958-10-07 | 1961-01-31 | Walker Lab Inc | Aluminum nicotinate compositions for hypercholesteremia |
DE1102973B (de) | 1960-03-25 | 1961-03-23 | Bayer Ag | Verfahren zur Herstellung von hoch gereinigten Kallikrein-Praeparaten |
DE1170417B (de) | 1960-11-08 | 1964-05-21 | Recip Ab | Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung |
DE1154810B (de) | 1961-04-01 | 1963-09-26 | Knoll Ag | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
GB984810A (en) | 1961-10-05 | 1965-03-03 | Farmaceutici Italia | Polypeptides |
US3262977A (en) | 1962-03-10 | 1966-07-26 | Chinoin Gyogyszer Es Vegyeszet | N-aralkyl-1, 1-diphenyl-propylamine derivatives |
US3228943A (en) | 1962-06-11 | 1966-01-11 | Lumilysergol derivatives | |
US3338899A (en) | 1962-07-09 | 1967-08-29 | Aron Samuel | 3-phenyl-5-amino-1, 2, 4-oxadiazole compounds |
US3238215A (en) | 1963-10-17 | 1966-03-01 | Sterling Drug Inc | 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines |
NL127065C (fr) | 1964-04-22 | |||
NL6514807A (fr) | 1964-11-18 | 1966-05-20 | ||
FR1460571A (fr) | 1965-06-10 | 1966-03-04 | Innothera Lab Sa | Composés thiényl acétiques et leur préparation |
FR6087M (fr) | 1967-01-10 | 1968-06-04 | ||
DE1670827C3 (de) | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
US3511836A (en) | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
FR2003097A1 (en) | 1968-03-02 | 1969-11-07 | Takeda Chemical Industries Ltd | Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive |
GB1218591A (en) | 1968-04-03 | 1971-01-06 | Delalande Sa | Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation |
FR2092133B1 (fr) | 1970-05-06 | 1974-03-22 | Orsymonde | |
US3669968A (en) | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
BE795735A (fr) | 1972-03-06 | 1973-06-18 | Cerm Cent Europ Rech Mauvernay | Nouvelles ethylenediamines substituees a activite cardiovasculaire |
GB1435139A (en) | 1972-08-17 | 1976-05-12 | Sumitomo Chemical Co | Thiazole derivatives |
US3985758A (en) | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
US4146643A (en) | 1973-12-18 | 1979-03-27 | Sandoz Ltd. | Increasing vigilance or treating cerebral insufficiency with substituted vincamines |
NL175059C (nl) | 1974-02-23 | Boehringer Mannheim Gmbh | Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten. | |
US4338322A (en) | 1975-07-02 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same |
US4466972A (en) | 1977-06-20 | 1984-08-21 | Sandoz Ltd. | Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them |
DE2733747C2 (de) | 1977-07-27 | 1979-09-27 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von 2,2 Dichlorhydrazobenzol |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
JPS55301A (en) | 1978-02-14 | 1980-01-05 | Yamanouchi Pharmaceut Co Ltd | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation |
IT1094076B (it) | 1978-04-18 | 1985-07-26 | Acraf | Cicloalchiltriazoli |
SE429652B (sv) | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
DE2845770A1 (de) | 1978-10-19 | 1980-04-30 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
EP0094159B1 (fr) | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dérivés de la dihydropyridine, leur préparation et leur application |
DE3382204D1 (de) | 1982-10-15 | 1991-04-18 | Kyowa Hakko Kogyo Kk | 1,4-dihydropyridin-derivate. |
US4567175A (en) | 1983-06-03 | 1986-01-28 | Tanabe Seiyaku Co., Ltd. | 8-Chloro-1,5-benzothiazepine derivatives |
GB8403866D0 (en) | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
US4672068A (en) | 1984-05-04 | 1987-06-09 | Fujirebio Kabushiki Kaisha | Antihypertensive 1,4-dihydropyridines having a conjugated ester |
NZ212895A (en) | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
WO1987000838A1 (fr) | 1985-07-29 | 1987-02-12 | Santen Pharmaceutical Co., Ltd. | Nouveaux derives de benzothiazine |
US4885284A (en) | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
DK171349B1 (da) | 1986-11-14 | 1996-09-16 | Hoffmann La Roche | Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler |
ATE61588T1 (de) | 1987-08-03 | 1991-03-15 | Delagrange Lab | 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
EP0832069B1 (fr) | 1995-06-07 | 2003-03-05 | Pfizer Inc. | DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B) |
EP0944602A1 (fr) | 1996-11-27 | 1999-09-29 | Pfizer Inc. | Amides inhibant la secretion d'apo b et/ou la proteine mtp |
JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
PA8471201A1 (es) | 1998-06-16 | 2000-09-29 | Pfizer Prod Inc | Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea |
JP2003221376A (ja) | 2001-11-21 | 2003-08-05 | Japan Tobacco Inc | Cetp活性阻害剤 |
DK1533292T3 (da) | 2002-08-30 | 2007-06-04 | Japan Tobacco Inc | Dibenzylaminforbindelse og medicinsk anvendelse deraf |
JP3630676B2 (ja) * | 2002-08-30 | 2005-03-16 | 日本たばこ産業株式会社 | ジベンジルアミン化合物及びその医薬用途 |
US6653334B1 (en) | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
WO2005100298A1 (fr) | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Inhibiteurs de cetp |
DOP2005000123A (es) | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
JP2008520645A (ja) | 2004-11-23 | 2008-06-19 | ファイザー・プロダクツ・インク | ジベンジルアミン化合物および誘導体 |
UY30117A1 (es) * | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | Compuesto amina trisustituido |
-
2007
- 2007-01-03 US US11/619,277 patent/US7919506B2/en not_active Expired - Fee Related
- 2007-02-26 EP EP07705672A patent/EP1996564A1/fr not_active Withdrawn
- 2007-02-26 MX MX2008010863A patent/MX2008010863A/es active IP Right Grant
- 2007-02-26 CA CA2645294A patent/CA2645294C/fr not_active Expired - Fee Related
- 2007-02-26 CA CA2717249A patent/CA2717249A1/fr not_active Abandoned
- 2007-02-26 SG SG2011077658A patent/SG176418A1/en unknown
- 2007-02-26 AP AP2008004604A patent/AP2008004604A0/xx unknown
- 2007-02-26 EA EA200801815A patent/EA200801815A1/ru unknown
- 2007-02-26 RS RSP-2008/0410A patent/RS20080410A/sr unknown
- 2007-02-26 AU AU2007226261A patent/AU2007226261B2/en not_active Expired - Fee Related
- 2007-02-26 JP JP2008558924A patent/JP5075843B2/ja not_active Expired - Fee Related
- 2007-02-26 BR BRPI0709003-0A patent/BRPI0709003A2/pt not_active Application Discontinuation
- 2007-02-26 WO PCT/IB2007/000527 patent/WO2007105050A1/fr active Application Filing
- 2007-02-26 KR KR1020087022006A patent/KR101058312B1/ko not_active IP Right Cessation
- 2007-03-01 NL NL2000514A patent/NL2000514C2/nl not_active IP Right Cessation
- 2007-03-08 PE PE2007000255A patent/PE20080118A1/es not_active Application Discontinuation
- 2007-03-08 UY UY30196A patent/UY30196A1/es not_active Application Discontinuation
- 2007-03-08 GT GT200700020A patent/GT200700020A/es unknown
- 2007-03-09 AR ARP070100980A patent/AR059803A1/es unknown
- 2007-03-09 DO DO2007000047A patent/DOP2007000047A/es unknown
- 2007-03-09 TW TW096108174A patent/TW200738652A/zh unknown
-
2008
- 2008-08-20 IL IL193571A patent/IL193571A/en not_active IP Right Cessation
- 2008-08-22 NO NO20083641A patent/NO20083641L/no not_active Application Discontinuation
- 2008-08-29 CR CR10264A patent/CR10264A/es not_active Application Discontinuation
- 2008-09-09 TN TNP2008000347A patent/TNSN08347A1/fr unknown
- 2008-09-10 MA MA31225A patent/MA30271B1/fr unknown
- 2008-09-10 EC EC2008008729A patent/ECSP088729A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DOP2007000047A (es) | 2007-09-15 |
KR20080091861A (ko) | 2008-10-14 |
EP1996564A1 (fr) | 2008-12-03 |
SG176418A1 (en) | 2011-12-29 |
US20070213371A1 (en) | 2007-09-13 |
CR10264A (es) | 2008-09-23 |
MX2008010863A (es) | 2008-09-03 |
NO20083641L (no) | 2008-09-29 |
TNSN08347A1 (fr) | 2009-12-29 |
IL193571A0 (en) | 2009-05-04 |
CA2645294A1 (fr) | 2007-09-20 |
PE20080118A1 (es) | 2008-02-22 |
EA200801815A1 (ru) | 2009-02-27 |
CA2645294C (fr) | 2011-08-30 |
RS20080410A (en) | 2009-09-08 |
AP2008004604A0 (en) | 2008-10-31 |
JP5075843B2 (ja) | 2012-11-21 |
AR059803A1 (es) | 2008-04-30 |
GT200700020A (es) | 2007-11-15 |
UY30196A1 (es) | 2007-10-31 |
ECSP088729A (es) | 2008-10-31 |
US7919506B2 (en) | 2011-04-05 |
TW200738652A (en) | 2007-10-16 |
NL2000514C2 (nl) | 2009-03-31 |
CA2717249A1 (fr) | 2007-09-20 |
IL193571A (en) | 2012-12-31 |
KR101058312B1 (ko) | 2011-08-22 |
AU2007226261A1 (en) | 2007-09-20 |
WO2007105050A1 (fr) | 2007-09-20 |
NL2000514A1 (nl) | 2007-09-11 |
JP2009531312A (ja) | 2009-09-03 |
BRPI0709003A2 (pt) | 2011-06-21 |
AU2007226261B2 (en) | 2012-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN07200A1 (fr) | Dibenzylamines et derives | |
MA30272B1 (fr) | Derives de dibenzylamines servant d'inhibiteurs de cetp. | |
TNSN06447A1 (fr) | Composes heteroaryle et phenylsulfamoyle substitues | |
MA27532A1 (fr) | Piperidines a substituant phenyle, destinees a etre utilisees comme activateurs de ppar | |
TNSN07100A1 (fr) | Derives de 1, 2, 3, 4- tetrahydroquinoleine substitues en position 2 et a substituant 4-amino | |
MA31683B1 (fr) | Composes et procedes pour moduler fxr | |
MA33119B1 (fr) | Derives de benzofuranyle utilises comme inhibiteurs de la glucokinase | |
RS20050395A (en) | Ppar activators | |
MA30271B1 (fr) | Dibenzylamines et derives | |
TW200610525A (en) | Substituted heteroaryl-and phenylsulfamoyl compounds | |
MA32035B1 (fr) | Composes tricycliques servant de modulateurs de synthese de tnf-alpha et d'inhibiteurs de pde4 | |
MA31087B1 (fr) | Derives d'amide et d'ester d'indazolyle pour traiter des troubles medies par le recepteur de glucocorticoïde. | |
WO2010079431A3 (fr) | Composés pour la prévention et le traitement de maladies cardiovasculaires | |
TW200508222A (en) | Quinoline and quinoxaline compounds | |
ATE332887T1 (de) | Naturstoffe und deren derivate zur prävention und behandlung von herzkreislauf-, leber- und nierenerkrankungen und für kosmetische anwendungen | |
MA32150B1 (fr) | Inhibiteurs heterocycliques de la stearoyl-coa desaturase | |
WO2009048249A3 (fr) | Composition destinée à prévenir ou à traiter des troubles du métabolisme lipidique contenant de la fucoxanthine ou un extrait de plante marine la contenant | |
AP2002002427A0 (en) | Ppar compounds. | |
DE60141636D1 (de) | Phospholipidderivate von valproinsäure und ihre kombinationen | |
NZ596130A (en) | Fragrance composition having good sleep-inducing effect | |
TW200616964A (en) | Quinoline compounds | |
TNSN08346A1 (fr) | Derives de dibenzylamines servant d'inhibiteurs de cetp | |
MX2007009108A (es) | Derivados de imidazol. | |
MA37748A1 (fr) | Composés d'azétidine et de pipéridine utiles comme inhibiteurs de pde10 | |
EA201070459A1 (ru) | Аминооксимные производные 2- и/или 4-замещенных андростанов и андростенов в качестве лекарственных средств для лечения сердечно-сосудистых нарушений |